Largest Pharma Companies by Market Cap in 2026
Largest Pharmaceutical Companies by Market Cap in 2026
Pulled directly from the AlphaSense platform, this list features the top 50 companies by market capitalization in the pharmaceutical industry in 2026. The list is updated in real time to provide the most accurate picture of today’s leading pharma companies.
Note: This list only features pharmaceutical companies that are listed on U.S. stock exchanges.
Key Takeaways:
- Eli Lilly is the largest pharma company in the world, with a market cap of $1.12 trillion.
- Eli Lilly is followed by Johnson & Johnson ($606.67 billion), AbbVie ($438.25 billion), Merck & Co ($311.22 billion), and Novartis ($293.75 billion).
- The largest market cap companies on the list are biopharma companies, which combine biotech with traditional pharma.
- Companies from the United States and Europe mostly dominate market cap rankings.
Last updated Jul 20, 2026
| Company Name | Market Cap | Revenue | Net Income | EPS | Employees | Sentiment |
|---|---|---|---|---|---|---|
| Eli Lilly and Co (LLY) | 1.11 T | 49.00 B | 10.59 B | 11.71 | 47,000 | 32+4% |
| Johnson & Johnson (JNJ) | 604.07 B | 89.33 B | 14.07 B | 5.79 | 139,800 | 53-23% |
| AbbVie Inc (ABBV) | 448.71 B | 57.37 B | 4.28 B | 2.39 | 55,000 | 42-13% |
| Merck & Co Inc (MRK) | 312.19 B | 63.92 B | 17.12 B | 6.74 | 75,000 | 8-26% |
| Novartis AG (NOVN.CH) | 290.03 B | 53.22 B | 11.94 B | 5.87 | 75,883 | 20-36% |
| Novo Nordisk A/S (NOVO B.DK) | 221.86 B | 303.14 B | 100.99 B | 22.63 | 77,406 | -11+22% |
| Amgen Inc (AMGN) | 197.43 B | 34.13 B | 4.09 B | 7.56 | 28,000 | 43-8% |
| Gilead Sciences Inc (GILD) | 165.63 B | 28.73 B | 480.00 M | 0.38 | 17,600 | 59+22% |
| Pfizer Inc (PFE) | 141.75 B | 62.46 B | 8.03 B | 1.41 | 81,000 | 58+47% |
| AstraZeneca PLC (AZN.GB) | 129.63 B | 54.98 B | 7.04 B | 4.50 | 94,300 | 28-20% |
| Bristol-Myers Squibb Co (BMY) | 124.26 B | 47.64 B | -8.95 B | -4.41 | 34,100 | 13-30% |
| Vertex Pharmaceuticals Inc (VRTX) | 123.59 B | 11.10 B | -535.60 M | -2.08 | 6,100 | 25-1% |
| Sanofi SA (SAN.FR) | 105.54 B | 45.17 B | 5.56 B | 4.43 | 82,878 | -4-33% |
| GSK PLC (GSK.GB) | 101.79 B | 31.53 B | 2.58 B | 0.62 | 68,629 | -10-59% |
| Regeneron Pharmaceuticals Inc (REGN) | 69.31 B | 14.09 B | 4.41 B | 38.34 | 15,158 | 320% |
| Take-Two Interactive Software Inc (TTWO) | 54.23 B | 5.63 B | -4.48 B | -25.58 | 12,928 | 4-36% |
| argenx SE (ARGX.BE) | 53.34 B | 2.58 B | 833.04 M | 12.78 | 1,639 | 10-10% |
| Haleon PLC (HLN.GB) | 44.15 B | 11.23 B | 1.44 B | 0.16 | 24,622 | 2-97% |
| Revolution Medicines Inc (RVMD) | 39.52 B | N/A | -600.09 M | -3.58 | 616 | -26-1% |
| Teva Pharmaceutical Industries Ltd (TEVA.IL) | 36.80 B | 16.62 B | -1.64 B | -1.45 | 35,686 | 13-30% |
| Alnylam Pharmaceuticals Inc (ALNY) | 36.18 B | 2.35 B | -278.16 M | -2.18 | 2,230 | 37-1% |
| Onico SA (ONC.PL) | 33.44 B | 114.66 M | -6.85 M | -0.91 | 63 | N/A |
| Zoetis Inc (ZTS) | 31.70 B | 9.29 B | 2.49 B | 5.47 | 13,800 | -55-139% |
| Biogen Inc (BIIB) | 29.98 B | 9.82 B | 1.63 B | 11.18 | 7,605 | 1-19% |
| Royalty Pharma PLC (RPRX) | 25.12 B | 2.26 B | 858.98 M | 1.91 | 99 | 73+12% |
| Roivant Sciences Ltd (ROIV) | 24.84 B | 29.05 M | -171.98 M | -0.24 | 750 | -26-9% |
| Moderna Inc (MRNA) | 24.22 B | 3.14 B | -3.56 B | -9.28 | 5,800 | -15-34% |
| Insmed Inc (INSM) | 23.34 B | 381.03 M | -913.77 M | -5.57 | 1,271 | 29+2% |
| Incyte Corp (INCY) | 23.20 B | 4.41 B | 32.62 M | 0.15 | 2,617 | 42+19% |
| BioNTech SE (BNTX) | 23.08 B | 2.75 B | -665.30 M | -0.85 | 6,772 | -24-10% |
| United Therapeutics Corp (UTHR) | 22.67 B | 2.99 B | 1.20 B | 24.64 | 1,305 | 3-15% |
| Viatris Inc (VTRS) | 20.00 B | 14.33 B | -634.20 M | -0.53 | 32,000 | 32-17% |
| Neurocrine Biosciences Inc (NBIX) | 17.51 B | 2.41 B | 341.30 M | 3.29 | 1,800 | 7-15% |
| Genmab AS (GMAB.DK) | 17.33 B | 3.12 B | 1.09 B | 16.93 | 2,638 | 8-12% |
| Ascendis Pharma A/S (ASASND) | 16.20 B | 368.70 M | -378.08 M | -4.69 | 1,017 | 7-1% |
| BridgeBio Pharma Inc (BBIO) | 15.91 B | 127.42 M | -535.76 M | -2.88 | 730 | 12-5% |
| Jazz Pharmaceuticals PLC (JAZZ) | 15.45 B | 4.06 B | 560.12 M | 8.65 | 2,800 | 41-32% |
| Exelixis Inc (EXEL) | 14.22 B | 2.30 B | 521.27 M | 1.76 | 1,147 | 17-10% |
| Elanco Animal Health Inc (ELAN) | 12.80 B | 4.43 B | 338.00 M | 0.68 | 9,450 | 85-14% |
| Madrigal Pharmaceuticals Inc (MDGL) | 12.59 B | 317.38 M | -465.89 M | -21.90 | 528 | 21-3% |
| Axsome Therapeutics Inc (AXSM) | 11.83 B | 432.16 M | -287.22 M | -5.99 | 589 | 22+4% |
| BioMarin Pharmaceutical Inc (BMRN) | 11.42 B | 2.95 B | 426.86 M | 2.21 | 3,040 | 9-9% |
| Bio-Techne Corp (TECH) | 11.24 B | 1.21 B | 168.10 M | 1.05 | 3,100 | 10-31% |
| Summit Therapeutics Inc (SMMT) | 10.91 B | N/A | -221.31 M | -0.31 | 159 | -9+3% |
| Dr Reddy's Laboratories Ltd (EQDRREDDY.IN) | 10.45 B | 325.54 B | 56.54 B | 67.78 | 27,811 | -35-13% |
| Krystal Biotech Inc (KRYS) | 10.33 B | 333.45 M | 89.16 M | 3.00 | 275 | 7-4% |
| Arrowhead Pharmaceuticals Inc (ARWR) | 10.31 B | 545.21 M | -599.49 M | -5.00 | 609 | 16+13% |
| Cytokinetics Inc (CYTK) | 9.96 B | 19.22 M | -589.53 M | -5.26 | 498 | 50+60% |
| Abivax SA (ABVX.FR) | 9.87 B | N/A | N/A | N/A | 69 | -23+12% |
| Corcept Therapeutics Inc (CORT) | 9.82 B | 685.45 M | 141.21 M | 1.23 | 500 | 28+19% |
Frequently Asked Questions
What are the largest pharma companies by market capitalization in 2026?
The largest pharmaceutical companies by market cap in 2026 are Eli Lilly, Johnson & Johnson, AbbVie, AstraZeneca, and Merck.
What does market cap represent, and how is it calculated?
Market cap reflects a company’s overall value in the eyes of investors. The companies listed in the table above are those with the highest valuations based on data from stock exchanges, financial reports, and trusted market intelligence tools.
Market cap is calculated by multiplying a company’s current stock price by its total number of outstanding shares. This metric helps investors easily compare companies within a given industry based on valuation.
Why do pharma companies have such high market caps?
The pharma industry is a trillion-dollar industry, and most pharma companies earn billions in revenue each year. The industry is constantly growing due to consistent demand for pharmaceutical products and a business model that combines high-risk, high-reward R&D with legally protected market exclusivity.
Pharma companies typically have large market caps because of the immense value of their patented drug portfolios, strong R&D pipelines, global distribution networks, and recurring revenue from long-term treatment. Other key factors that influence the market cap of pharma companies include drug approvals, clinical trial results, patent expiration timelines, regulatory developments (FDA, EMA), M&A activity, and global healthcare demand trends.
What is the difference between biotech and pharma companies, and does this list contain both?
While both are subsectors of the healthcare industry, traditional pharmaceutical companies typically focus on chemically synthesized drugs, while biotech firms develop their medicines from living organisms. Biotech firms are typically newer and smaller than traditional pharma companies. Biotech firms also tend to focus more on novel, experimental therapies, while pharma companies typically focus on large-scale manufacturing and distribution of established drugs.
This list does include biotech companies, since these are still considered part of the pharmaceutical industry. Additionally, many companies operate as both biotech and pharma companies, developing a range of therapeutic products — these are considered “biopharma” and include such companies like Pfizer, Eli Lilly, Novo Nordisk, Novartis, AbbVie, Johnson & Johnson, and more.
Are generic drug manufacturers included in the largest pharma companies list?
Some generic drug companies — including Teva, Viatris, Novartis, and Pfizer — are included in this list because their market caps are sufficiently high. However, most top-ranking pharmaceutical firms do specialize in branded or specialty drugs.
Do these rankings include privately held pharmaceutical companies?
No. Market capitalization is a metric that only applies to publicly traded companies.
Where can I find reliable real-time market cap data for pharma companies?
You can find reliable market cap data through financial data platforms, company filings, and market analytics tools. Leading corporations, financial services firms, and consultancies use AlphaSense as their source of truth for reliable, real-time data on companies and market trends across various industries.
AlphaSense aggregates 10,000+ private, public, premium, and proprietary external data sources in one platform, including:
- Healthcare news, industry reports, company reports, clinical trial updates, and regulatory content from sources such as PubMed, ClinicalTrials.gov, World Health Organization, MedlinePlus, and FDA
- Over 1,500 research providers including Wall Street Insights®, a premier analyst research collection for corporate professionals
- Expert call transcript library with over 240,000 vetted interviews (including with competitors, suppliers, doctors, and KOLs)
AlphaSense’s industry-leading AI and generative AI technology help users cut through the noise — surfacing the most relevant insights from across this content so you can move faster, go deeper, and gain a true competitive edge.
Where can I find market cap data on other sectors?
You can find additional market cap data on the following pages: